Form 4: Sotera Health Director Karen Flynn Receives Equity Grant of Restricted Stock Units

Sentiment:

Insider Transaction Report


Sotera Health Co. Director Karen Flynn was granted 19,132 restricted stock units (RSUs) on May 22, 2025, as part of the company's 2020 Omnibus Incentive Plan.

Summary

  • Karen Flynn, a Director of Sotera Health Co. (SHC), acquired 19,132 shares of Common Stock through a grant of Restricted Stock Units (RSUs) on May 22, 2025.
  • These RSUs were granted under the Sotera Health Company 2020 Omnibus Incentive Plan and each RSU represents the right to receive one share of Common Stock.
  • The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date (May 22, 2025), or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting.
  • Vesting is contingent upon Ms. Flynn's continued service as a non-employee director of Sotera Health Co. through the vesting date.
  • Following this transaction, Ms. Flynn beneficially owns a total of 39,221 securities, comprising the newly granted 19,132 RSUs and 20,089 previously held shares of Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the transaction represents a routine equity grant to a director, which aligns management interests with shareholders. It is a standard compensation practice and does not indicate any negative operational or financial issues.

Positives

  • The grant of restricted stock units to a director aligns their financial interests with those of the shareholders, encouraging long-term value creation.
  • Utilization of the 2020 Omnibus Incentive Plan demonstrates the company's commitment to incentivizing key personnel through equity compensation.

Risks

  • No specific new risks are disclosed in this Form 4 filing, as it primarily reports a change in beneficial ownership related to compensation.

Future Outlook

The vesting schedule for the granted RSUs indicates an expectation of Karen Flynn's continued service as a non-employee director for at least the next year or until the next annual shareholders meeting, aligning her incentives with the company's future performance.

Management Comments

  • The grant of 19,132 restricted stock units to Director Karen Flynn reflects a decision by the company to provide equity-based compensation under its 2020 Omnibus Incentive Plan.

Industry Context

The granting of restricted stock units (RSUs) to non-employee directors is a common practice across publicly traded companies, particularly in the healthcare and industrial services sectors, as a form of non-cash compensation designed to attract and retain qualified board members and align their interests with long-term shareholder value.

Comparison to Industry Standards

  • The use of Restricted Stock Units (RSUs) as a component of non-employee director compensation is a widely adopted practice across various industries, including healthcare and specialized services, aligning with global corporate governance benchmarks.
  • This method of compensation is comparable to practices seen in companies like Steris plc (STE) or Avantor, Inc. (AVTR), which also utilize equity grants to incentivize their board members and foster long-term commitment.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Policy ImplementationThe grant of Restricted Stock Units (RSUs) to Director Karen Flynn was made pursuant to the terms of an RSU agreement under the existing Sotera Health Company 2020 Omnibus Incentive Plan.05/22/2025This action demonstrates the ongoing implementation of the company's approved incentive compensation framework, designed to align director interests with long-term shareholder value and retain key board members.

Related Party Transactions

  • The transaction involves the grant of equity compensation to Karen Flynn, a Director of Sotera Health Co., which constitutes a related party transaction as it is between the company and a member of its board of directors. This is a standard form of director compensation.

Stakeholder Impact

  • Shareholders: The equity grant aligns the director's financial interests with those of the shareholders, potentially fostering decisions that enhance long-term shareholder value.
  • Employees: While not directly impacting employees, the use of an incentive plan for directors may reflect a broader compensation philosophy within the company.

Next Steps

  • The granted Restricted Stock Units (RSUs) will vest in full on the earlier of the first anniversary of the grant date (May 22, 2025) or the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to continued service.

Key Dates

DateDescription
05/22/2025Date of grant for 19,132 Restricted Stock Units (RSUs) to Karen Flynn.
05/27/2025Date the Form 4 was signed by Alexander Dimitrief, Attorney-in-Fact for Karen Flynn.
05/22/2026Earliest potential vesting date for the RSUs (first anniversary of grant date).

Keywords

Sotera Health, SHC, Form 4, Insider Transaction, Restricted Stock Units, RSU, Equity Grant, Director Compensation, Karen Flynn, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.